TY  - GEN
AU  - Chang-Douglass,Stacey
AU  - Mulvihill,Caroline
AU  - Pilling,Steve
TI  - Cannabis-based medicinal products: summary of NICE guidance
SN  - 1756-1833
PY  - 2020///0514
KW  - Antiemetics
KW  - therapeutic use
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Cannabidiol
KW  - Cannabinoid Receptor Agonists
KW  - Chronic Pain
KW  - drug therapy
KW  - Decision Making, Shared
KW  - Dronabinol
KW  - analogs & derivatives
KW  - Drug Resistant Epilepsy
KW  - Drug and Narcotic Control
KW  - Epilepsies, Myoclonic
KW  - Humans
KW  - Lennox Gastaut Syndrome
KW  - Medical Marijuana
KW  - Multiple Sclerosis
KW  - complications
KW  - Muscle Spasticity
KW  - Nausea
KW  - chemically induced
KW  - Needs Assessment
KW  - Physicians, Primary Care
KW  - Practice Guidelines as Topic
KW  - Specialization
KW  - United Kingdom
KW  - Vomiting
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1136/bmj.m1108
ER  -